Cargando…
Role of NF-E2 related factor 2 (Nrf2) on chemotherapy resistance in acute myeloid leukemia (AML) and the effect of pharmacological inhibition of Nrf2
Cytarabine (Ara-C) and Daunorubicin (Dnr) forms the backbone of acute myeloid leukemia (AML) therapy. Drug resistance and toxic side effects pose a major threat to treatment success and hence alternate less toxic therapies are warranted. NF-E2 related factor-2 (Nrf2), a master regulator of antioxida...
Autores principales: | Karathedath, Sreeja, Rajamani, Bharathi M., Musheer Aalam, Syed Mohammed, Abraham, Ajay, Varatharajan, Savitha, Krishnamurthy, Partha, Mathews, Vikram, Velayudhan, Shaji Ramachandran, Balasubramanian, Poonkuzhali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432104/ https://www.ncbi.nlm.nih.gov/pubmed/28505160 http://dx.doi.org/10.1371/journal.pone.0177227 |
Ejemplares similares
-
Plasma imatinib levels and ABCB1 polymorphism influences early molecular response and failure-free survival in newly diagnosed chronic phase CML patients
por: Rajamani, Bharathi M., et al.
Publicado: (2020) -
Modulating retinoid-X-receptor alpha (RXRA) expression sensitizes chronic myeloid leukemia cells to imatinib in vitro and reduces disease burden in vivo
por: Rajamani, Bharathi M., et al.
Publicado: (2023) -
Nrf2 and the Nrf2-Interacting Network in Respiratory Inflammation and Diseases
por: Carlson, Jennifer, et al.
Publicado: (2020) -
The NRF2-p97-NRF2 negative feedback loop
por: Shakya, Aryatara, et al.
Publicado: (2023) -
Linking Klotho, Nrf2, MAP kinases and aging
por: Balasubramanian, Priya, et al.
Publicado: (2010)